; and (iv) a detailed account of the input, data, evidence, or opinions the Agency has received from other agencies or components of the Federal Government that the Agency may have used to reach a conclusion on such case. (C) For each priority case of an anomalous health incident determined to largely display the core characteristics of an anomalous health incident established by the Intelligence Community Experts Panel, including each case for which the Agency does not have a credible alternative explanation, a detailed description of such case. (2) Anomalous health incident sensors (A) A list of all types of sensors that the Agency has developed or deployed with respect to reports of anomalous health incidents, including, for each type of sensor, the deployment location, the date and the duration of the employment of such type of sensor, and, if applicable, the reason for removal. (B) A list of entities to which the Agency has provided unrestricted access to data from sensors associated with anomalous health incidents. (C) A list of requests for support the Agency has received from elements of the Federal Government regarding sensor development, testing, or deployment, and a description of the support provided in each case. (D) A description of each emitter signature that the Agency prioritizes as a threat obtained by sensors associated with anomalous health incidents in Agency holdings since 2016, and an explanation of such prioritization. (d) Additional submissions Concurrent with the submission of the report required by subsection (b), the Director of the Central Intelligence Agency shall submit to the appropriate committees of Congress— (1) a report on the length of time, from the time of initial application, for an applicant for payment under the Expanded Care Program of the Central Intelligence Agency to receive a determination from the Agency, disaggregated by qualifying injuries and qualifying injuries to the brain